Odyssey Health Inc's Comment on Sales, Marketing and Customers
The company is developing two primary products: CardioMap, a rapid EKG device pending FDA clearance, and the Save-A-Life (SAL) choking rescue device, also awaiting FDA approval. The SAL device is intended for emergency removal of lodged masses from the throats of choking victims. Competitors in the choking device market include Dechoker, LifeVac, and Act+Fast, which offer various anti-choking solutions and training devices. In the EKG device market, CardioResting (Nasiff) provides a full-featured 12-lead PC-based cardiology system; however, no competitor currently offers digital heart mapping similar to CardioMap. Customers and markets referenced in filings include Act+Fast, CardioResting (Nasiff), Dechoker, and LifeVac.
Odyssey Health Inc’s Comment on Sales, Marketing and Customers
The company is developing two primary products: CardioMap, a rapid EKG device pending FDA clearance, and the Save-A-Life (SAL) choking rescue device, also awaiting FDA approval. The SAL device is intended for emergency removal of lodged masses from the throats of choking victims. Competitors in the choking device market include Dechoker, LifeVac, and Act+Fast, which offer various anti-choking solutions and training devices. In the EKG device market, CardioResting (Nasiff) provides a full-featured 12-lead PC-based cardiology system; however, no competitor currently offers digital heart mapping similar to CardioMap. Customers and markets referenced in filings include Act+Fast, CardioResting (Nasiff), Dechoker, and LifeVac.
Sources:
Odyssey Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Odyssey Health Inc’s corporate clients.
For your research, we’ve provided 9 tables on Odyssey Health Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
